Could an accidental discovery lead to a cure for sepsis?

Diagnosis of familial amyloid polyneuropathy can be both tricky and slow – but a different approach could hold the answer

If prospective registration is enforced for clinical trials, questionable results become easier to spot

When you crunch the numbers on drug development, are the costs of cancer drugs justified?

Eleftherios P. Diamandis, Hold ’em for Life Chair in Prostate Cancer Biomarkers, University of Toronto.

UTIs account for many antibiotic prescriptions; could a new POC test help selective prescribing?

Regulating the production of alpha-synuclein may be a new approach for treating Parkinson’s

Some common strategies to dispel vaccine myths may instead be making the situation worse.

The lack of scientific terms available in sign language could be holding deaf scientists back…

Are current ethical guidelines for clinical studies letting pregnant women down?